[go: up one dir, main page]

DE69524626D1 - Äusseres hauptmembranprotein cd von moraxella - Google Patents

Äusseres hauptmembranprotein cd von moraxella

Info

Publication number
DE69524626D1
DE69524626D1 DE69524626T DE69524626T DE69524626D1 DE 69524626 D1 DE69524626 D1 DE 69524626D1 DE 69524626 T DE69524626 T DE 69524626T DE 69524626 T DE69524626 T DE 69524626T DE 69524626 D1 DE69524626 D1 DE 69524626D1
Authority
DE
Germany
Prior art keywords
protein
pellet
remaining
bacterial
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69524626T
Other languages
English (en)
Other versions
DE69524626T2 (de
Inventor
Yan-Ping Yang
Robin E Harkness
E Myers
Ursula Mcguinness
H Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23281593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69524626(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of DE69524626D1 publication Critical patent/DE69524626D1/de
Application granted granted Critical
Publication of DE69524626T2 publication Critical patent/DE69524626T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69524626T 1994-10-24 1995-10-23 Äusseres hauptmembranprotein cd von moraxella Expired - Lifetime DE69524626T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32858994A 1994-10-24 1994-10-24
PCT/CA1995/000604 WO1996012733A1 (en) 1994-10-24 1995-10-23 Major outer membrane protein cd of moraxella

Publications (2)

Publication Number Publication Date
DE69524626D1 true DE69524626D1 (de) 2002-01-24
DE69524626T2 DE69524626T2 (de) 2002-07-04

Family

ID=23281593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69524626T Expired - Lifetime DE69524626T2 (de) 1994-10-24 1995-10-23 Äusseres hauptmembranprotein cd von moraxella

Country Status (14)

Country Link
US (1) US6121427A (de)
EP (1) EP0787144B1 (de)
JP (1) JP3534771B2 (de)
CN (1) CN1161376C (de)
AT (1) ATE210678T1 (de)
AU (1) AU706832B2 (de)
CA (1) CA2203540C (de)
DE (1) DE69524626T2 (de)
DK (1) DK0787144T3 (de)
ES (1) ES2169166T3 (de)
MX (1) MX9702952A (de)
PT (1) PT787144E (de)
RU (1) RU2186582C2 (de)
WO (1) WO1996012733A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335018B1 (en) * 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
CA2253942A1 (en) 1996-05-10 1997-11-20 Biogen, Inc. Common gamma chain blocking agents
US5977337A (en) * 1997-06-03 1999-11-02 Connaught Laboratories Limited Lactoferrin receptor genes of Moraxella
US7105164B1 (en) 1998-04-07 2006-09-12 Sanofi Pasteur Limited HIV-specific cytotoxic T-cell responses
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810084D0 (en) * 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6541616B1 (en) 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
JP2003500363A (ja) * 1999-05-24 2003-01-07 ゾーマ(ユーエス) エルエルシー 滲出を伴う中耳炎を有するヒトにおけるbpiタンパク質産物の治療的使用
US7517968B2 (en) * 2003-07-07 2009-04-14 Syracuse University Rapid and inexpensive method for the purification of proteorhodopsin
RU2601158C1 (ru) * 2015-05-12 2016-10-27 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) ШТАММЫ ВИДА Streptococcus pneumoniae (ВАРИАНТЫ) И СПОСОБ ПОЛУЧЕНИЯ ИЗ НИХ ПРОТЕКТИВНОЙ БЕЛОКСОДЕРЖАЩЕЙ ФРАКЦИИ, ОБЛАДАЮЩЕЙ ВНУТРИВИДОВОЙ ИММУНОГЕННОЙ АКТИВНОСТЬЮ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
US5110908A (en) * 1986-12-31 1992-05-05 Praxis Biologics, Inc. Haemophilus influenzae peptides and proteins
DE3715840A1 (de) * 1987-05-12 1988-12-01 Boehringer Mannheim Gmbh Fuer ein lytisch wirksames, chimaeres protein kodierende rekombinante dna und ihre verwendung
US5393658A (en) * 1987-09-28 1995-02-28 New Horizons Diagnostics Corporation Immunoassay method for the rapid identification of detergent treated antigens
JP2516841B2 (ja) * 1989-04-14 1996-07-24 ユニリーバー・ナームローゼ・ベンノートシヤープ 抽出方法
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5552146A (en) * 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
ATE190502T1 (de) * 1993-05-13 2000-04-15 American Cyanamid Co Herstellung und verwendungen von los-verminderten aussenmembran-proteinen von gram-negativen kokken
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US5556755A (en) * 1993-09-29 1996-09-17 The Research Foundation Of State University Of New York Method for detecting Branhamella catarrhalis

Also Published As

Publication number Publication date
WO1996012733A1 (en) 1996-05-02
RU2186582C2 (ru) 2002-08-10
CN1174559A (zh) 1998-02-25
AU706832B2 (en) 1999-06-24
JP3534771B2 (ja) 2004-06-07
MX9702952A (es) 1997-06-28
JPH10508303A (ja) 1998-08-18
EP0787144A1 (de) 1997-08-06
AU3695395A (en) 1996-05-15
DK0787144T3 (da) 2002-01-14
CN1161376C (zh) 2004-08-11
ES2169166T3 (es) 2002-07-01
HK1009453A1 (en) 1999-09-17
CA2203540A1 (en) 1996-05-02
CA2203540C (en) 2005-04-05
PT787144E (pt) 2002-06-28
ATE210678T1 (de) 2001-12-15
DE69524626T2 (de) 2002-07-04
US6121427A (en) 2000-09-19
EP0787144B1 (de) 2001-12-12

Similar Documents

Publication Publication Date Title
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
Domont et al. Natural anti-snake venom proteins
ATE229979T1 (de) Transferrinrezeptor protein aus moraxella
ATE210678T1 (de) Äusseres hauptmembranprotein cd von moraxella
Omori-Satoh et al. The antihemorrhagic factor, erinacin, from the European hedgehog (Erinaceus europaeus), a metalloprotease inhibitor of large molecular size possessing ficolin/opsonin P35 lectin domains
Slomiany et al. Mucus glycoprotein of human saliva: differences in the associated and covalently bound lipids with caries
BR9506272A (pt) Análogo isolado e purificado de proteina hin 47 haemophilus influenzae moçécula quimérica molécula de ácido nucleico purificada e isolada plasmídeo recombinante célula tranformada processo para produzir um análogo de porteina hin 47 haemophilus influenzae composicão imunogênica processo para determinir a presença de anticorpos processo para determinir a presença de proteina hin 47 em uma amostra e estojo diagnóstico hin 47
KR960701096A (ko) 그룹 B 스트렙토코커스의 많은 균주들에 대한 면역성을 제공하는 세포 표면 단백질인 Rib 단백질, 그 단백질의 정제방법, 시약키트 및 제약조성물(PROTEIN RIB. A CELL SURFACE PROTEIN THAT CONFERS IMMUNITY TO MANY STRAINS OF THE GROUP B STREPTOCOCCUS; PROCESS FOR PURIFICATION OF THE PROTEIN, PEAGENT KIT AND PHARMACEUTICAL COMPOSITION)
DE69122240D1 (de) Antigen-wirkende proteine von borrelia burgdorferi
AU2529095A (en) Vaccine against mycobacterial infections
Faust et al. Degradation of the parasporal crystal produced by Bacillus thuringiensis var. kurstaki
Ouazana et al. Biochemical characterization of the cuticle collagen of the nematode Caenorhabditis elegans
DK172329B1 (da) Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding
Kemparaju et al. Purification of a basic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) venom: characterization of antigenic, catalytic and pharmacological properties
Bernheimer et al. Toxins of the sea anemone Epiactis prolifera
ES2171563T3 (es) Nueva familia de inhibidores de proteasas, y otras sustancias de actividad biologica.
ATE283065T1 (de) Mehrzweckvakzine gegen umhüllte viren
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
Farah et al. Isolation of protein factors from opossum (Didelphis albiventris) serum which protect against Bothrops jararaca venom
Ryan et al. Major hemolymph proteins from larvae of the black swallowtail butterfly, Papilio polyxenes
McCrone Spider venoms: biochemical aspects
Treadwell et al. Purification of the ‘link proteins’ from bovine articular cartilage and comparison with ‘link proteins’ from nasal septum
Koga et al. Composition of major outer membrane proteins of Vibrio vulnificus isolates: effect of different growth media and iron deficiency
DK1005487T3 (da) Ydre 74 kD-membranprotein fra Moraxella catarrhalis
Mountford et al. Fractionation of schistosome antigens by high performance electrophoretic chromatography and their screening for the ability to induce Th1 lymphocyte activity

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings